William Byrd, MD
Orthopaedic Surgery · Virginia Beach, VANPI 1528301520
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $80,050 of the $100,929 with a category attached, or 79.3%. 12 manufacturers reported payments, led by Medacta USA, Inc. at 52.2% of the total. 2025 is the largest year on record at $46,003, more than ten times the $3,493 reported in 2019. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $590.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$53K
- Kyocera Medical Technologies, Inc.$27K
- Medical Device Business Services, Inc.$15K
- Johnson & Johnson$3K
- Stryker$3K
- Zimmer Biomet$488
- plus $722 from 6 others
What the payments were for
- Consulting fees$80,05079%
- Travel & lodging$12,79313%
- Food & beverage$8,0868%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 80 | $52,681 |
| Kyocera Medical Technologies, Inc. | 4 | $27,220 |
| Medical Device Business Services, Inc. | 21 | $14,647 |
| Johnson & Johnson | 27 | $2,646 |
| Stryker | 18 | $2,524 |
| Zimmer Biomet | 5 | $488 |
| Smith+Nephew | 6 | $233 |
| Exactech, Inc. | 4 | $226 |
| Flower Orthopedics Coporation | 1 | $143 |
| Bioventus LLC | 3 | $70 |
| Deroyal Industries, Inc. | 1 | $26 |
| Convatec Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$25,410
- GMK Sphere Revision System$23,591
- ACTIS$2,871
- MAKO$1,910
- ATTUNE$1,091
- AMISTEM$828
- SPHERIKA$625
- AMIStem H Femoral Stems$274
- Velys$245
- Bioinductive Implant with Arthroscopic Delivery System - Medium$142
- ROSA$139
- Persona$139
- VELYS Hip Navigation$108
- Kincise Surgical Automated System$108
- MPACT$104
- TFN-Advance$104
How this compares
$100,929 in reported general payments places this provider in the 90th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 406 | $914 |
| Celecoxib | 22 | $565 |
| Methylprednisolone | 45 | $325 |
| Amoxicillin | 126 | $149 |
| Ondansetron OdtOndansetron | 13 | $138 |
| Cephalexin | 12 | $116 |
| Oxycodone Hcl | 25 | $105 |
| Clindamycin Hcl | 18 | $16 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Virginia Beach
- James DowdVirginia Beach$6.1M
- Joseph GonduskyVirginia Beach$1.2M
- Blake MooreVirginia Beach$100K
- Dale YoungNorth Chesterfield$10.9M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.